ProShares MSCI EAFE Dividend Growers (EFAD)

40.46 -0.10  -0.24% BATS Feb 21, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 40.51
Discount or Premium to NAV -0.11%
Turnover Ratio 31.00%
1 Year Fund Level Flows 16.11M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -1.92% -1.71% -1.14% 69
3M 4.37% 4.53% 5.59% 66
6M 11.90% 12.16% 11.36% 37
YTD -0.64% -0.42% 0.66% 71
1Y 13.60% 13.66% 17.36% 81
3Y 9.25% 9.55% 10.82% 66
5Y 3.00% 3.29% 6.30% 97
10Y -- -- 7.37% --
15Y -- -- 5.86% --
20Y -- -- 3.85% --
As of Feb. 21, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.65% 0.65% 0.00%
Stock 99.35% 99.35% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Jan. 31, 2020

Region Exposure

Americas 1.12%
North America 1.12%
Latin America 0.00%
Greater Europe 64.36%
United Kingdom 27.43%
Europe Developed 36.93%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 34.52%
Japan 18.54%
Australasia 9.23%
Asia Developed 6.75%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Jan. 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.53%
Communication Services 4.63%
Consumer Cyclical 11.80%
Consumer Defensive 13.59%
Energy 1.03%
Financial Services 11.91%
Healthcare 18.79%
Industrials 19.94%
Real Estate 3.31%
Technology 4.50%
Utilities 6.98%
As of Jan. 31, 2020

Stock Market Capitalization

Giant 17.06%
Large 45.17%
Medium 37.77%
Small 0.00%
Micro 0.00%
As of Jan. 31, 2020

Stock Style Exposure

Large Cap Value 10.40%
Large Cap Blend 28.74%
Large Cap Growth 23.08%
Mid Cap Value 9.10%
Mid Cap Blend 10.57%
Mid Cap Growth 18.11%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of Jan. 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
DIM Sartorius Stedim Biotech SA 1.32% -- --
RYM Ryman Healthcare Ltd 1.30% -- --
SSE SSE PLC 1.29% -- --
KRX Kingspan Group PLC 1.28% -- --
UCB UCB SA 1.27% -- --
HLMA Halma PLC 1.26% -- --
LGEN Legal & General Group PLC 1.26% -- --
AVV AVEVA Group PLC 1.25% -- --
BA. BAE Systems PLC 1.25% -- --
IMB Imperial Brands PLC 1.24% -- --
As of Jan. 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks investment results, before fees and expenses, that track the performance of the MSCI EAFE Dividend Masters Index (the "index"). The index, constructed and maintained by MSCI, targets companies that are currently members of the MSCI EAFE Index ("MSCI EAFE") and have increased dividend payments each year for at least 10 years. The index contains a minimum of 40 stocks, which are equally weighted. Under normal circumstances, the fund will invest at least 80% of its total assets in component securities.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class International Equity
Broad Category Equity
Category Name Foreign Large Growth
Prospectus Objective Equity-Income
Fund Owner Firm Name ProShares
Benchmark Index
MSCI EAFE Dividend Masters NR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Ryan Dofflemeyer 0.57 yrs
Scott Hanson 3.17 yrs

Net Fund Flows

1M 3.274M
3M 9.350M
6M 10.41M
YTD 3.274M
1Y 16.11M
3Y 86.90M
5Y 126.27M
10Y --
As of Jan. 31, 2020

Risk Info

Beta (5Y) 0.8309
Max Drawdown (All) 19.72%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.0944
30-Day Rolling Volatility 11.60%
Daily Value at Risk (VaR) 1% (All) 2.41%
Monthly Value at Risk (VaR) 1% (All) 8.23%

Fundamentals

Dividend Yield TTM (2-21-20) 2.06%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 19.28
Weighted Average Price to Sales Ratio 1.516
Weighted Average Price to Book Ratio 2.425
Weighted Median ROE 17.72%
Weighted Median ROA 7.41%
Forecasted Dividend Yield 2.81%
Forecasted PE Ratio 17.60
Forecasted Price to Sales Ratio 1.394
Forecasted Price to Book Ratio 2.165
Number of Holdings 88
As of Jan. 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.25%
Forecasted Book Value Growth 7.71%
Forecasted Cash Flow Growth 5.22%
Forecasted Earnings Growth 5.83%
Forecasted Revenue Growth 5.63%
As of Jan. 31, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 8/19/2014
Termination Date
Last Annual Report Date 5/31/2019
Last Prospectus Date 10/1/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.